These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7660511

  • 1. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR.
    Urology; 1995 Sep; 46(3):365-9. PubMed ID: 7660511
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 3. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 4. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Aug 01; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec 01; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 6. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Sep 01; 6(9):727-32. PubMed ID: 9298581
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.
    Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 9. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR, Schwartz AM, Shchepotin EI, Uskokovic M, Shchepotin IB.
    Clin Cancer Res; 1998 Nov 15; 4(11):2869-76. PubMed ID: 9829754
    [Abstract] [Full Text] [Related]

  • 11. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
    Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL.
    Cancer Res; 2000 Feb 15; 60(4):779-82. PubMed ID: 10706079
    [Abstract] [Full Text] [Related]

  • 12. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 13. Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo.
    Vegesna V, O'Kelly J, Said J, Uskokovic M, Binderup L, Koeffle HP.
    Anticancer Res; 2003 Mar 15; 23(1A):283-9. PubMed ID: 12680225
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z, Akhter J, Pourgholami MH, Morris DL.
    Anticancer Res; 2008 Mar 15; 28(6A):3757-61. PubMed ID: 19189661
    [Abstract] [Full Text] [Related]

  • 15. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
    Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA.
    Cancer Epidemiol Biomarkers Prev; 2002 Jun 15; 11(6):555-63. PubMed ID: 12050097
    [Abstract] [Full Text] [Related]

  • 16. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY, Norman AW, Chen DL, Sun GW, Uskokovic M, Koeffler HP.
    Proc Natl Acad Sci U S A; 1990 May 15; 87(10):3929-32. PubMed ID: 2339131
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 18. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
    Anzano MA, Smith JM, Uskoković MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL.
    Cancer Res; 1994 Apr 01; 54(7):1653-6. PubMed ID: 8137276
    [Abstract] [Full Text] [Related]

  • 19. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Apr 01; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 20. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J, Pełczyńska M, Madej J, Dzimira S, Kuśnierczyk H, Kutner A, Szelejewski W, Opolski A.
    Steroids; 2004 Sep 01; 69(10):629-35. PubMed ID: 15465107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.